Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis

Background The prevalence of non‐alcohol‐related fatty liver disease (NAFLD) varies between 19% and 33% in different populations. NAFLD decreases life expectancy and increases risks of liver cirrhosis, hepatocellular carcinoma, and the requirement for liver transplantation. Uncertainty surrounds rel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2021-07, Vol.2021 (7), p.CD013157
Hauptverfasser:	Gurusamy, Kurinchi Selvan, Komolafe, Oluyemi, Buzzetti, Elena, Linden, Audrey, Best, Lawrence MJ, Madden, Angela M, Roberts, Danielle, Chase, Thomas JG, Fritche, Dominic, Freeman, Suzanne C, Cooper, Nicola J, Sutton, Alex J, Milne, Elisabeth Jane, Wright, Kathy, Pavlov, Chavdar S, Davidson, Brian R, Tsochatzis, Emmanuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Bayes Theorem Bias Dietary Supplements Dietary Supplements - adverse effects Diets Endocrine & metabolic Fatty liver FATTY LIVER IN OBESITY (K76.0) Gastroenterology & hepatology Humans Liver disorders Medical interventions Medicine General & Introductory Medical Sciences Network Meta-Analysis Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - therapy Obesity & overweight Obesity in adults Odds Ratio Proportional Hazards Models Randomized Controlled Trials as Topic Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!